Bioteque (4107.TWO) Earnings Analysis

Bioteque (4107.TWO) next reports earnings on 2026-08-07, consensus EPS 2.16 TWD. Last quarter (2026-05-08) it beat with EPS 2.09 TWD vs 2.09 TWD est (0%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E 15.03.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 4107.TWO next report earnings?

Next earnings date2026-08-07
Consensus EPS estimate2.16 TWD
Revenue estimate0.58B

4107.TWO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-082.09 TWD2.09 TWD0%Beat
2026-03-052.24 TWD2.31 TWD-3%Miss
2025-03-041.92 TWDn/an/an/a
2024-11-072.07 TWDn/an/an/a

Beat rate: 1/2 (50%) over reported quarters with consensus data.

4107.TWO valuation and analyst view

Trailing P/E15.03
Trailing EPS7.924 TWD
Price / book2.44
Dividend yield4.20%
Market cap8.21B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Bioteque (4107.TWO)'s next earnings date?

Bioteque is next scheduled to report on 2026-08-07, with a consensus EPS estimate of 2.16 TWD and revenue estimate of 0.58B.

Did 4107.TWO beat earnings last quarter?

In its 2026-05-08 report, 4107.TWO posted EPS of 2.09 TWD versus a 2.09 TWD estimate — a beat of 0%.

What is 4107.TWO's earnings track record?

Over the last 2 reported quarters with consensus data, 4107.TWO beat estimates 1 times (50%).

What is 4107.TWO's current P/E ratio and EPS?

4107.TWO trades at a trailing P/E of 15.03 on trailing EPS of 7.923508296452203 TWD.

What do analysts rate 4107.TWO?

4107.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.